PKCθ pseudosubstrate peptide inhibitor, myristoylated (TFA)
PKCθ pseudosubstrate peptide inhibitor, myristoylated TFA is a synthetic peptide that can be used to study the mechanism of action of PKCθ[1].
Product Specifications
UNSPSC
12352209
Target
PKC
Type
Peptides
Related Pathways
Epigenetics; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/pkcθ-pseudosubstrate-peptide-inhibitor-myristoylated-tfa.html
Purity
98.03
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
O=C([C@@H](NC(CCCCCCCCCCCCC)=O)CC(C)C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CS)=O)CCCCN)=O)C(C)C)=O)CC1=CNC=N1)=O)CC2=CNC=N2)=O)C(C)C)=O)CCCCN)=O)C)=O)CCC(N)=O)=O)CCCCN)=O)[C@H](CC)C)=O)C)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)CC3=CNC=N3.OC(C(F)(F)F)=O.[x]
Molecular Formula
C105H184N36O21S.xC2HF3O2
Molecular Weight
2318.88 (free base)
References & Citations
[1]Koon HW, et al. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther. 2005 Sep;314 (3) :1393-400.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880149-100 1x 100 µL
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400281-500 1x 500 µL
Insulin (E2-E3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details